Patients and methods IGF 1 and binding proteins IGFBP 1 and 3 serum levels were measured at baseline and after 3 and 6 months of treatment in a selected group of patients with prostate cancer who were randomly assigned to treatment with bicalutamide, bicalutamide plus anastrozole or bicalutamide plus tamoxifen in a comparative study investigating the role of pharmacological medication in the development of bicalutamide induced gynecomastia [url=https://fastpriligy.top/]buy priligy on the internet without a prescription[/url] DNA damage induced by alkylating agents and repair pathways
